Skip to content

Effect of intake of supplements containing ornithine on human health.

Effect of intake of supplements containing ornithine on human health. - Ornithine clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000022941
Enrollment
40
Registered
2017-09-24
Start date
2016-06-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy people

Interventions

Ornithine supplements 2 tablets/day 12 weeks Placebo supplements 2 tablets/day 12 weeks

Sponsors

Laboratory of Systematic Forest and Forest Products Science, Faculty of Agriculture, Kyushu University
Lead Sponsor
Fuculuty of Humanity-Oriented Science and Eingineering, Kindai University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Non smokers (2) Persons who will generally be judged as healthy (3) Persons who have never suffered from asthma (4) Persons who have never developed any allegic reaction to medicines, foods, or other substances. (5) Persons who will give written informed consent by themselves

Exclusion criteria

Exclusion criteria: (1) Persons who have any dietary supplements, quasi drugs or medicines which cause same or similar efficay with the effect evaluated in this study (2) Persons who changed their habitats of supplements whitin 4 weeks. (3) Persons who work in night shift or in day and night shift (4) Persons who have been treated their illness or prevention in a clinic at their informed consent (5) Persons with their medical histories as follows: serious diseases of Sugar metabolism,lipid metabolism, liver function, renal function, heart, circulatory, respiratory, endocrine system, immune system, or mental illness of the nervous system (6) persons with the medical histories of alcoholism or drug dependence (7) persons who might be developed allergic reaction to foods. (8) Persons who are pregnant, breast-feeding, or hope to be pregnant during the study preiod (9) persons who had always participated in or will participate in any other clinical trial (to use foods/medicine/quasi medicine/medical device) (10) persons who will not be judged suitable to the participants by the investigator.

Design outcomes

Primary

MeasureTime frame
GOT GPT gamma-GTP

Secondary

MeasureTime frame
Blood pressure Serum glucose LAP HbA1c HDL-C LDL-C Triglyicerides Urea nitrogen Creatinine Uric acid

Countries

Japan

Contacts

Public ContactKuniyoshi shimizu

Faculty of Agriculture, Kyushu University Laboratory of Systematic Forest and Forest Products Science

shimizu@agr.kyushu-u.ac.jp092-642-3002

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026